Risk of venous thromboembolism with bevacizumab in cancer patients
- PMID: 19351936
- DOI: 10.1001/jama.2009.440
Risk of venous thromboembolism with bevacizumab in cancer patients
Comment on
-
Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis.JAMA. 2008 Nov 19;300(19):2277-85. doi: 10.1001/jama.2008.656. JAMA. 2008. PMID: 19017914
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources